Current pharmaceutical biotechnology
Gut Microecosystem and Metabolic Dysfunction-Associated Steatotic Liver Disease: Exploring the Crosstalk and Advancing Therapeutic Strategies.
Xin-Yi Zhou, Xin Wen, Qi-Qi Huang, Yi-Han Zhou, Ting Wang, Zhang-E Xiong
Published: 202510.2174/0113892010393279251013013142
Abstract
Metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as a global health concern. In recent years, the gut microbiota, often referred to as the body's "second genome," has been recognized as playing a crucial role in the pathog…
Preview only. Read the full abstract at the source